Alps Advisors Inc Ligand Pharmaceuticals Inc Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.01 - $107.56 $7 - $82,606	-768 Reduced 7.67%	9,239 $796,000
Q2 2022 Aug 11, 2022	SELL	$74.52 - $117.06 $545,262 - $856,528	-7,317 Reduced 42.24%	10,007 $893,000
Q1 2022 May 16, 2022	SELL	$94.99 - $151.56 $191,499 - $305,544	-2,016 Reduced 10.42%	17,324 $1.95 Million
Q4 2021 Feb 09, 2022	SELL	$127.69 - $165.85 $139,692 - $181,439	-1,094 Reduced 5.35%	19,340 $2.99 Million
Q3 2021 Nov 15, 2021	SELL	$102.33 - $144.73 $142,238 - $201,174	-1,390 Reduced 6.37%	20,434 $2.85 Million
Q2 2021 Aug 11, 2021	SELL	$113.03 - $155.64 $820,710 - $1.13 Million	-7,261 Reduced 24.96%	21,824 $2.86 Million
Q1 2021 May 07, 2021	BUY	$99.52 - $215.83 $2,488 - $5,395	25 Added 0.09%	29,085 $4.43 Million
Q4 2020 Feb 03, 2021	BUY	$80.55 - $106.05 $689,508 - $907,788	8,560 Added 41.76%	29,060 $2.89 Million
Q3 2020 Nov 04, 2020	SELL	$89.56 - $126.72 $125,204 - $177,154	-1,398 Reduced 6.38%	20,500 $1.95 Million
Q2 2020 Aug 05, 2020	SELL	$68.28 - $123.65 $553,955 - $1 Million	-8,113 Reduced 27.03%	21,898 $2.45 Million
Q1 2020 May 06, 2020	SELL	$63.37 - $107.88 $338,459 - $576,187	-5,341 Reduced 15.11%	30,011 $2.18 Million
Q4 2019 Feb 07, 2020	SELL	$96.94 - $113.59 $249,717 - $292,607	-2,576 Reduced 6.79%	35,352 $3.69 Million
Q3 2019 Nov 04, 2019	SELL	$86.25 - $120.16 $543,720 - $757,488	-6,304 Reduced 14.25%	37,928 $3.78 Million
Q2 2019 Aug 07, 2019	SELL	$107.38 - $129.34 $934,742 - $1.13 Million	-8,705 Reduced 16.44%	44,232 $5.05 Million
Q1 2019 May 01, 2019	BUY	$105.93 - $142.47 $221,393 - $297,762	2,090 Added 4.11%	52,937 $6.66 Million
Q4 2018 Feb 04, 2019	BUY	$128.36 - $272.13 $1.5 Million - $3.18 Million	11,691 Added 29.86%	50,847 $6.9 Million
Q3 2018 Oct 25, 2018	BUY	$211.18 - $274.49 $1.77 Million - $2.3 Million	8,372 Added 27.2%	39,156 $10.7 Million
Q2 2018 Aug 02, 2018	BUY	$150.77 - $207.98 $1.12 Million - $1.54 Million	7,398 Added 31.63%	30,784 $6.38 Million
Q2 2018 Jul 25, 2018	SELL	$150.77 - $207.98 $741,637 - $1.02 Million	-4,919 Reduced 17.38%	23,386 $3.2 Million
Q1 2018 May 01, 2018	BUY	$138.63 - $182.62 $681,920 - $898,307	4,919 Added 21.03%	28,305 $4.68 Million
Q4 2017 Feb 05, 2018	BUY	$128.36 - $147.04 $357,225 - $409,212	2,783 Added 13.51%	23,386 $3.2 Million
Q3 2017 Nov 03, 2017	BUY	$120.91 - $137.94 $2.49 Million - $2.84 Million	20,603	20,603 $2.81 Million

Others Institutions Holding LGND

# of Institutions

267

Shares Held

18M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.9B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account